Every earnings call for CIPLA — management tone, guidance, KPIs and promise tracking, quarter by quarter.
CIPLA · 7 transcripts · Healthcare · latest Q1 FY27Cipla Limited has 7 earnings calls on record here, a Healthcare company, most recently Q1 FY27. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue ₹7,119 cr (+2% YoY); EBITDA Margin 16.7%; PAT ₹789 cr. Highest ever Q1 revenue of INR 7,119 crores, reflecting a 2% YoY growth.
Read full transcript & analysisFY26 Revenue ₹28,163 cr; FY26 EBITDA Margin 21.0%; FY26 PAT ₹3,879 cr. FY26 Revenue reached INR28,163 crores, with Q4 Revenue at INR6,541 crores.
Read full transcript & analysisTotal Revenue ₹7,074 cr; EBITDA Margin 17.7 percentage; Profit After Tax ₹676 cr. Revenue of Rs 7,074 crores, flat YoY despite Revlimid decline.
Read full transcript & analysisTotal Revenue ₹7,589 cr (+8% YoY); EBITDA Margin 25 percentage; Profit After Tax ₹1,351 cr. All-time high quarterly revenue of INR 7,589 crores with 8% YoY growth.
Read full transcript & analysisTotal Revenue ₹6,957 cr (+4% YoY); EBITDA Margin 25.6 percentage; Profit After Tax ₹1,298 cr (+10% YoY). Revenue of INR 6,957 crores with 4% YoY growth.
Read full transcript & analysisQ4 Revenue ₹6,730 cr (+9% YoY); Annual Revenue ₹27,548 cr (+8% YoY); Q4 EBITDA Margin 22.8 percentage. One India business surpassed landmark of INR 11,000 crores revenue.
Read full transcript & analysisRevenue ₹7,073 cr (+8% YoY); EBITDA Margin 28.0% (+2% YoY); PAT ₹1,571 cr. Quarterly revenue of ₹7,073 crores, up 8% YoY.
Read full transcript & analysis